1. J&J Hit With $8 Billion Jury Award Over Antipsychotic Drug  The Wall Street Journal
  2. Jury says J&J must pay $8 billion in case over male breast growth linked to Risperdal  Reuters
  3. UPDATE 3-Jury says J&J must pay $8 bln in case over male breast growth linked to Risperdal  Yahoo Finance
  4. Phila. Jury Returns $8 Billion Verdict Against Johnson & Johnson Over Risperdal | The Legal Intelligencer  Law.com
  5. BREAKING: J&J Slammed With $8B Verdict In Philly Risperdal Case  Law360
  6. View full coverage on Google News

Johnson & Johnson must pay $8 billion in punitive damages to a man who previously won $680,000 over his claims that it failed to warn that young men using its antipsychotic drug Risperdal could grow breasts, a Philadelphia jury said on Tuesday.Johnson & Johnson must pay $8 billion in punitive damages to a man who previousl...

J&J must pay $8 billion in case over male breast growth linked to Risperdal: jury - Reuters

Johnson & Johnson must pay $8 billion in punitive damages to a man who previously won $680,000 over his claims that it failed to warn that young men using its antipsychotic drug Risperdal could grow breasts, a Philadelphia jury said on Tuesday. The Philadelphia Court of Common Pleas jury's verdictJohnson & Johnson must pay $8 billion in punitive damages to a man who previously won $680,000 over his claims that it failed to warn that young men using its antipsychotic drug Risperdal could grow breasts, a Philadelphia jury said on Tuesday. The Philadelphia Court of Common Pleas jury's verdict

UPDATE 3-Jury says J&J must pay $8 bln in case over male breast growth linked to Risperdal

Jury says J&J must pay $8 billion in case over male breast growth linked to Risperdal

Jury says J&J must pay $8 billion in case over male breast growth linked to Risperdal

A jury in Philadelphia hit the drug giant with the staggering payout.A jury in Philadelphia hit the drug giant with the staggering payout.

Johnson & Johnson was ordered to pay at least $25 million to a woman who said she contracted a rare asbestos-related cancer through decades of dailyJohnson & Johnson was ordered to pay at least $25 million to a woman who said she contracted a rare asbestos-related cancer through decades of daily

Johnson & Johnson Hit with $25 Million Talc Verdict; Also Cleared by Another Jury

“Jury says Johnson & Johnson must pay US$8-billion in case over male breast growth linked to #Risperdal via ⁦@globebusiness⁩ https://t.co/EVIXgFzsYA”

André Picard on Twitter: "Jury says Johnson & Johnson must pay US$8-billion in case over male breast growth linked to #Risperdal via ⁦@globebusiness⁩ https://t.co/EVIXgFzsYA"

“A Philadelphia jury on Tuesday ordered Johnson & Johnson to pay $8 billion in damages to a Maryland man who said his use of J&J’s antipsychotic Risperdal as a child caused enlarged breasts and the company failed to properly warn of this risk. https://t.co/IyvWwyONaV”

Paul Vieira on Twitter: "A Philadelphia jury on Tuesday ordered Johnson & Johnson to pay $8 billion in damages to a Maryland man who said his use of J&J’s antipsychotic Risperdal as a child caused enlarged breasts and the company failed to properly warn of this risk. https://t.co/IyvWwyONaV"

The Philadelphia jury deliberating in the first punitive damages trial over Johnson & Johnson's conduct in marketing the antispychotic drug Risperdal has slammed the company with an $8 billion verdict.The Philadelphia jury deliberating in the first punitive damages trial over Johnson & Johnson's conduct in marketing the antispychotic drug Risperdal has slammed the company with an $8 billion verdict.

Phila. Jury Returns $8 Billion Verdict Against Johnson & Johnson Over Risperdal | The Legal Intelligencer

A Philadelphia jury hammered a Johnson & Johnson unit with an $8 billion punitive damages verdict on Tuesday after agreeing the company had recklessly ignored the risks that the antipsychotic drug Risperdal could lead to breast growth in adolescent boys as it pushed the medication for use in children.A Philadelphia jury hammered a Johnson & Johnson unit with an $8 billion punitive damages verdict on Tuesday after agreeing the company had recklessly ignored the risks that the antipsychotic drug Risperdal could lead to breast growth in adolescent boys as it pushed the medication for use in children.

J&J Slammed With $8B Verdict In Philly Risperdal Case - Law360

Johnson & Johnson must pay $8 billion in punitive damages to a man who previously won $680,000 over his claims that it failed to warn that young men using its antipsychotic drug Risperdal could grow breasts, a Philadelphia jury said on Tuesday.Johnson & Johnson must pay $8 billion in punitive damages to a man who previously won $680,000 over his claims that it failed to warn that young men using its antipsychotic drug Risperdal could grow breasts, a Philadelphia jury said on Tuesday.

J&J Must Pay $8 Billion in Case Over Male Breast Growth Linked to Risperdal: Jury

The Philadelphia Common Pleas Court jury agreed that Janssen Pharmaceuticals, a Johnson & Johnson subsidiary, illegally marketed the drug to pediatric physicians despite knowing its dangers.The Philadelphia Common Pleas Court jury agreed that Janssen Pharmaceuticals, a Johnson & Johnson subsidiary, illegally marketed the drug to pediatric physicians despite knowing its dangers.

Philly jury hands Johnson & Johnson $8 billion verdict in Risperdal case over male breast growth

NEW YORK — Johnson & Johnson must pay $8 billion US in punitive damages to a man who previously won $680,000 over his claims that it failed to warn that young men using its antipsychotic drug Risperdal could grow breasts, a Philadelphia jury said on Tuesday.NEW YORK — Johnson & Johnson must pay $8 billion US in punitive damages to a man who previously won $680,000 over his claims that it failed to warn that young men using its antipsychotic drug Risperdal could grow breasts, a Philadelphia jury said on Tuesday.

Jury awards man $8 billion US in punitive damages for drug that grew his breasts | Canoe

NEW YORK — Johnson & Johnson must pay $8 billion US in punitive damages to a man who previously won $680,000 over his claims that it failed to warn that young men using its antipsychotic drug Risperdal could grow breasts, a Philadelphia jury said on Tuesday.NEW YORK — Johnson & Johnson must pay $8 billion US in punitive damages to a man who previously won $680,000 over his claims that it failed to warn that young men using its antipsychotic drug Risperdal could grow breasts, a Philadelphia jury said on Tuesday.

Jury awards man $8 billion US in punitive damages for drug that grew his breasts | Canoe

It’s the first case in which a Pennsylvania jury had been able to consider awarding punitive damages in one of thousands of Risperdal cases pending in the stateIt’s the first case in which a Pennsylvania jury had been able to consider awarding punitive damages in one of thousands of Risperdal cases pending in the state

Jury says Johnson & Johnson must pay US$8-billion in case over male breast growth linked to Risperdal - The Globe and Mail